We noted no evidence of effect modification in different prespecified subgroups based on median age, initial median CRP concentration, previous history of COPD, severity of community-acquired pneumonia defined by the PSI score (I–III vs IV–V). The gene discussed is CRP; the disease is chronic obstructive pulmonary disease.